Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Growth hormone: a magical potion?]

J L Schlienger1, B Goichot

  • 1Service de médecine, CHRU, Hôpital de Hautepierre, Strasbourg, France.

La Revue De Medecine Interne
|October 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival of patients managed in France for duodenal neuroendocrine tumors (D-NET): a 20-year multicenter cohort study from the GTE group: a cohort study.

International journal of surgery (London, England)·2024
Same author

Controversy: Pros and cons screening of corticotropic deficiency after exogenous glucocorticoid therapy.

Annales d'endocrinologie·2018
Same author

Subclinical haemorrhage in non-functional adenomas.

Neuro-Chirurgie·2018
Same author

An unusual pituitary stalk lesion: What is the place of surgery?

Neuro-Chirurgie·2017
Same author

Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.

European journal of endocrinology·2015
Same author

Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters.

Clinical endocrinology·2015
Same journal

[Atypical low back pain].

La Revue de medecine interne·2026
Same journal

[Polycythemia associated chronic haemolysis].

La Revue de medecine interne·2026
Same journal

[Persistent headaches in a 55 year-old man].

La Revue de medecine interne·2026
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
See all related articles

Growth hormone (GH) is a valuable therapeutic tool, particularly for adults with GH deficiency, improving well-being and physical function. Rigorous clinical trials are essential to validate its efficacy in various conditions.

Area of Science:

  • Endocrinology and Metabolism
  • Hormone Axis Research
  • Physiological Regulation

Context:

  • The growth hormone (GH)-insulin-like growth factor (IGF-I) axis regulates critical bodily functions including bone health, cellular activity, metabolism, and protein anabolism.
  • Recombinant human growth hormone (rhGH) is now widely available, expanding therapeutic applications beyond pediatric short stature.
  • GH influences adult well-being, body composition, and physical activity, with potential applications in hypercatabolic states and cardiovascular conditions.

Purpose:

  • To review the multifaceted roles of the GH-IGF-I axis in human physiology.
  • To explore the therapeutic potential and current limitations of recombinant GH (rGH) treatment.
  • To emphasize the need for evidence-based evaluation of rGH in diverse clinical scenarios.

Related Experiment Videos

Summary:

  • The GH-IGF-I axis plays a vital role in adaptation to physiological stress and illness.
  • Recombinant GH offers significant benefits for adults with GH deficiency, improving quality of life and physical capacity.
  • While promising, GH is not a universal performance enhancer or anti-aging treatment; its efficacy requires validation in controlled trials.

Impact:

  • Establishes GH as a significant therapeutic agent with validated benefits for specific conditions.
  • Highlights the importance of ongoing research and clinical trials to define optimal use of GH.
  • Provides a balanced perspective on GH's capabilities, distinguishing established benefits from speculative applications.